Search

everythinglearnresearchcommunity

for

Search:↓

Targeting amphiregulin may improve treatment for fibrosis and cancer.

The glucocorticoid receptor helps protect skin from tumors and other issues.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

Diagnosing and managing Glucocorticoid Resistance Syndrome is complex due to genetic differences and varied symptoms.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Young patients are more likely to develop autoimmune diseases, while elderly patients are more prone to organ failure after DRESS.

EGFR inhibitors can cause skin issues, and managing these is important for treatment success.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

GABEB is a less severe skin condition caused by a gene mutation affecting collagen, leading to blisters and other symptoms.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

The study concluded that specific proteins are necessary to maintain the structure that holds epithelial cells tightly together.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Gastric trichobezoar in young children requires surgery and comprehensive care to prevent serious complications.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

Gefitinib can cause scalp skin issues and permanent hair loss.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.

All five human steroid 5α-reductase enzymes are found in the endoplasmic reticulum.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Topical human epidermal growth factor may effectively treat acne caused by cancer medication.

EPDS can cause recurring scalp sores and hair loss if not treated.

EGFR inhibitors can cause unusual localized hair growth.

Erlotinib can cause nonscarring hair loss and itchy skin.

GRF is not safe for tubal occlusion.

Valproic acid can cause a rare allergic reaction leading to fluid around the lungs and heart, which is treatable by changing medication.

Relapsing hepatitis A can cause prolonged abnormal liver tests even without symptoms.